Susanne Ingebrigtsen,
Agnethe Eltoft,
Thomas Karsten Kilvær
:
Zeroing in: achieving zero complications in lumbar puncture - a quality improvement initiative to reduce complications at the University Hospital of North Norway
BMJ Open Quality 11. juni 2025
DOI /
ARKIV
Susanne Ingebrigtsen,
Thomas Karsten Kilvær,
Agnethe Eltoft
:
Adult epilepsy in a North Norwegian County – incidence, prevalence, clinical features, and mortality (2012-2022)
Kevin C Elangwe,
Ellisiv B. Mathiesen,
Torunn Varmdal,
Bent Indredavik,
Agnethe Eltoft
:
Trends in reperfusion treatments, functional outcomes and mortality for first-ever ischaemic stroke in Norway from 2014 to 2021: The Norwegian Stroke Registry
European Stroke Journal 2025
DOI /
ARKIV
Michael D Hill,
Mayank Goyal,
Andrew M Demchuk,
Bijoy K Menon,
Thalia S Field,
William C Guest
m.fl.:
Efficacy and safety of nerinetide in acute ischaemic stroke in patients undergoing endovascular thrombectomy without previous thrombolysis (ESCAPE-NEXT): a multicentre, double-blind, randomised controlled trial
Mary-Helen Søyland,
Arnstein Tveiten,
Agnethe Eltoft,
Halvor Øygarden,
Torunn Varmdal,
Bent Indredavik
m.fl.:
Thrombolytic Treatment in Wake-Up Stroke: A Propensity Score-Matched Analysis of Treatment Effectiveness in the Norwegian Stroke Registry
Journal of the American Heart Association (JAHA) 2024
DOI /
ARKIV /
ARKIV
Kristin Busund,
Linn Hofsøy Steffensen,
Amalie Hauan,
Ellisiv B. Mathiesen,
Agnethe Eltoft
:
Geografiske forskjeller i trombolysebehandling ved akutt hjerneinfarkt
Tidsskrift for Den norske legeforening (Tidsskriftet) 2024
DOI /
ARKIV
Agnethe Eltoft,
Tom Wilsgaard,
Melinda Berg Roaldsen,
Mary-Helen Søyland,
Erik Lundström,
Jesper Petersson
m.fl.:
Statistical analysis plan for the randomized controlled trial Tenecteplase in Wake-up Ischaemic Stroke Trial (TWIST)
Melinda Berg Roaldsen,
Agnethe Eltoft,
Tom Wilsgaard,
Hanne Christensen,
Stefan T. Engelter,
Bent Indredavik
m.fl.:
Safety and efficacy of tenecteplase in patients with wake-up stroke assessed by non-contrast CT (TWIST): a multicentre, open-label, randomised controlled trial.
Christopher Elnan Kvistad,
Halvor Næss,
Bernt Harald Helleberg,
Titto Idicula,
Guri Hagberg,
Linn Marie Nordby
m.fl.:
Tenecteplase versus alteplase for the management of acute ischaemic stroke in Norway (NOR-TEST 2, part A): a phase 3, randomised, open-label, blinded endpoint, non-inferiority trial
Lancet Neurology 04. mai 2022
DOI /
ARKIV
Mary-Helen Søyland,
Arnstein Tveiten,
Agnethe Eltoft,
Halvor Øygarden,
Torunn Varmdal,
Bent Indredavik
m.fl.:
Wake-up stroke and unknown-onset stroke; occurrence and characteristics from the nationwide Norwegian Stroke Register
Anne Hege Aamodt,
Erik Taubøll,
Tom Eich Ele,
Luis Georg Romundstad,
Angelika Sorteberg,
Sean Ciaran Wallace
m.fl.:
Brain monitoring in hospitals needs to be strengthened
Tidsskrift for Den norske legeforening (Tidsskriftet) 2021
DOI /
ARKIV
Melinda Berg Roaldsen,
Haakon Lindekleiv,
Agnethe Eltoft,
Mirza Jusufovic,
Mary-Helen Søyland,
Jesper Petersson
m.fl.:
Tenecteplase in wake-up ischemic stroke trial: Protocol for a randomized-controlled trial
International Journal of Stroke 14. januar 2021
DOI /
ARKIV /
ARKIV
Agnethe Eltoft,
Kjell Arne Arntzen,
Tom Wilsgaard,
Ellisiv B. Mathiesen,
Stein Harald Johnsen
:
Interleukin-6 is an independent predictor of progres
sive atherosclerosis in the
carotid artery: The Tromsø Study
Agnethe Eltoft,
Kjell Arne Arntzen,
Tom Wilsgaard,
John-Bjarne Hansen,
Ellisiv B. Mathiesen,
Stein Harald Johnsen
:
Joint Effect of Carotid Plaque and C-Reactive Protein on First-Ever Ischemic Stroke and Myocardial Infarction?
Journal of the American Heart Association (JAHA) 2018
DOI /
ARKIV
Agnethe Eltoft,
Kjell Arne Arntzen,
John-Bjarne Hansen,
Tom Wilsgaard,
Ellisiv B. Mathiesen,
Stein Harald Johnsen
:
C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study
C-reactive protein in atherosclerosis - A risk marker but not a causal factor? A 13-year population-based longitudinal study: The Tromsø study.
Danni Zheng,
Shoichiro Sato,
Hisatomi Arima,
Emma Heeley,
Candice Delcourt,
Yongjun Cao
m.fl.:
Estimated GFR and the effect of intensive blood pressure lowering after acute intracerebral hemorrhage
American Journal of Kidney Diseases 2016
DOI /
ARKIV
Karl Øyvind Mikalsen,
Marte Stoksvik,
Karoline Skrøder,
Agnethe Eltoft,
Tommy Skar
:
Universitetssykehuset Nord-Norge bruker kunstig intelligens for bedre behandling av slag og blodpropp
Ole Morten Rønning,
Maria Kristin Carlsson,
Hege Ihle-Hansen,
Anne Hege Aamodt,
Arnstein Tveiten,
Agnethe Eltoft
m.fl.:
Overvåkning etter akutt hjerneslag bør bli bedre
Agnethe Eltoft
:
C-reactive protein and other circulating biomarkers in carotid
atherosclerosis and cardiovascular disease
The Tromsø Study 1994-2013
UiT Norges arktiske universitet 2018
ARKIV
Agnethe Eltoft,
Kjell Arne Arntzen,
Tom Wilsgaard,
Ellisiv B. Mathiesen,
Stein Harald Johnsen
:
Corrigendum to “Interleukin-6 is an independent predictor of progressive atherosclerosis in the carotid artery: The Troms? study” [Atherosclerosis 271 (April 2018) 1-8]